Canary’s TRXS Fund Pairs TRX Exposure With Staking Rewards
The Cboe BZX-traded product charges a 1.10% annual sponsor fee and may allocate up to 20% of staking rewards to fees.

Canary Capital’s TRXS gives U.S. investors brokerage-account exposure to TRON’s TRX token and seeks to add TRX through staking, with rewards reflected in the fund’s net asset value (NAV).
The fund began trading on Cboe BZX on Sept. 9. Its annual sponsor fee is 1.10%. The prospectus allows staking providers, the sponsor and the custodian to receive up to 20% of staking rewards in aggregate; the trust is expected to retain 80%. Rewards add TRX to the trust and are reflected in NAV, rather than promised as a separate payment to shareholders.
TRXS holds TRX directly. Its primary objective is to reflect the value of its TRX holdings, less expenses and liabilities, while its secondary objective is to earn additional TRX through TRON’s delegated proof-of-stake process.
Canary’s fund page displayed 90% of TRXS holdings as staked or queued for staking. That figure is a fund-page snapshot, not a stated fixed staking level.
The product provides a way to gain TRX exposure through a brokerage account without holding the token directly. TRXS is not registered under the Investment Company Act of 1940 and does not have the same protections and requirements as funds registered under that law. Its prospectus lists risks that include TRX price volatility, staking losses and slashing penalties.